Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-011111
Filing Date
2025-04-21
Accepted
2025-04-21 17:15:15
Documents
1
Period of Report
2025-04-17

Document Format Files

Seq Description Document Type Size
1 form4-04212025_050411.html 4  
1 form4-04212025_050411.xml 4 4063
  Complete submission text file 0001415889-25-011111.txt   5686
Mailing Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478
Business Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 (713) 489-8654
Tvardi Therapeutics, Inc. (Issuer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6800 KOLL CENTER PARKWAY PLEASANTON CA 94566
Business Address
Wirk Shaheen (Reporting) CIK: 0002050227 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36279 | Film No.: 25854362